Cargando…
Inflammatory cytokines in type 2 diabetes mellitus as facilitators of hypercoagulation and abnormal clot formation
BACKGROUND: The global burden of type 2 diabetes mellitus (T2DM), together with the presence of cardiovascular risk in this population, is reaching pandemic levels. A prominent feature of T2DM is chronic and systemic inflammation, with the accompanying presence of circulating and dysregulated inflam...
Autores principales: | Randeria, Shehan N., Thomson, Greig J. A., Nell, Theo A., Roberts, Timothy, Pretorius, Etheresia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6549308/ https://www.ncbi.nlm.nih.gov/pubmed/31164120 http://dx.doi.org/10.1186/s12933-019-0870-9 |
Ejemplares similares
-
Platelet activity and hypercoagulation in type 2 diabetes
por: Pretorius, Lesha, et al.
Publicado: (2018) -
Prevalence of readily detected amyloid blood clots in ‘unclotted’ Type 2 Diabetes Mellitus and COVID-19 plasma: a preliminary report
por: Pretorius, Etheresia, et al.
Publicado: (2020) -
Colorectal cancer is associated with increased circulating lipopolysaccharide, inflammation and hypercoagulability
por: de Waal, Greta M., et al.
Publicado: (2020) -
Hypercoagulation in COPD: the clot thickens
por: Rahaghi, Farbod N., et al.
Publicado: (2021) -
Platelet hyperactivity and fibrin clot structure in transient ischemic attack individuals in the presence of metabolic syndrome: a microscopy and thromboelastography(®) study
por: van Rooy, Mia-Jeanne, et al.
Publicado: (2015)